Tsong-yih Y. Ou

Taipei, TNQ, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 46 publications

Safety and antiviral activity of inhaled siRNA SNS812 for treatment of mild-to-moderate COVID-19: a phase 2 randomized trial.

Safety and antiviral activity of inhaled siRNA SNS812 for treatment of mild-to-moderate COVID-19: a phase 2 randomized trial.

Journal: Journal of biomedical science

Published: February 02, 2026

Preliminary Serological Evidence of Toxocara canis and Toxoplasma gondii Exposure Among Very Elderly Neuropsychiatric Patients in Taiwan.

Preliminary Serological Evidence of Toxocara canis and Toxoplasma gondii Exposure Among Very Elderly Neuropsychiatric Patients in Taiwan.

Journal: International journal of geriatric psychiatry

Published: December 24, 2025

Assessing the early sepsis warning system in the emergency department.

Assessing the early sepsis warning system in the emergency department.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: July 28, 2025

Regional Mortality From Chronic Liver Diseases in African Countries Attributable to Hepatitis B Virus and Hepatitis C Virus Infections From 1990 to 2021 and Projections to 2030.

Regional Mortality From Chronic Liver Diseases in African Countries Attributable to Hepatitis B Virus and Hepatitis C Virus Infections From 1990 to 2021 and Projections to 2030.

Journal: Open forum infectious diseases

Published: March 19, 2025

Nirmatrelvir-ritonavir significantly reduces severe COVID-19 outcomes in diverse Taiwanese populations: Comprehensive evidence from a large-scale longitudinal cohort study in Taiwan.

Nirmatrelvir-ritonavir significantly reduces severe COVID-19 outcomes in diverse Taiwanese populations: Comprehensive evidence from a large-scale longitudinal cohort study in Taiwan.

Journal: Journal of infection and public health

Published: September 30, 2024

A Phase 3, Randomized, Controlled Trial Evaluating the Efficacy and Safety of Ropeginterferon Alfa-2b in Patients with Moderate COVID-19.

A Phase 3, Randomized, Controlled Trial Evaluating the Efficacy and Safety of Ropeginterferon Alfa-2b in Patients with Moderate COVID-19.

Journal: Infectious diseases and therapy

Published: March 20, 2024

Global mortality of chronic liver diseases attributable to Hepatitis B virus and Hepatitis C virus infections from 1990 to 2019 and projections to 2030.

Global mortality of chronic liver diseases attributable to Hepatitis B virus and Hepatitis C virus infections from 1990 to 2019 and projections to 2030.

Journal: Journal of infection and public health

Published: December 16, 2023

Persistent dysregulation of cellular immunity following COVID-19 recovery despite minimal post-COVID-19 sequelae manifestation.

Persistent dysregulation of cellular immunity following COVID-19 recovery despite minimal post-COVID-19 sequelae manifestation.

Journal: The Journal of infection

Published: February 15, 2023

A global analysis of COVID-19 infection fatality rate and its associated factors during the Delta and Omicron variant periods: an ecological study.

A global analysis of COVID-19 infection fatality rate and its associated factors during the Delta and Omicron variant periods: an ecological study.

Journal: Frontiers in public health

Published: January 15, 2023

The association between tocilizumab and the secondary bloodstream infection maybe nonsignificant in hospitalized patients with SARS-CoV-2 infection: A cohort study.

The association between tocilizumab and the secondary bloodstream infection maybe nonsignificant in hospitalized patients with SARS-CoV-2 infection: A cohort study.

Journal: Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi

Published: September 13, 2022

Comparison of COVID-19 Resilience Index and Its Associated Factors across 29 Countries during the Delta and Omicron Variant Periods.

Comparison of COVID-19 Resilience Index and Its Associated Factors across 29 Countries during the Delta and Omicron Variant Periods.

Journal: Vaccines

Published: April 21, 2022

Nosocomial septicemia in COVID-19 nosocomial K. pneumoniae, A. baumannii, and Elizabethkingia meningoseptica septicemia in a patient of COVID-19.

Nosocomial septicemia in COVID-19 nosocomial K. pneumoniae, A. baumannii, and Elizabethkingia meningoseptica septicemia in a patient of COVID-19.

Journal: The Journal of infection

Published: March 30, 2022

Showing 1-12 of 46

Last Updated: 09/26/2026